Skip to main content

Advertisement

How I Treat:
Gunshot Wound

ADVERTISEMENT

How I Treat: Gunshot Wound Case Presentation

headshot of Dr Castater
Sponsored
Myriad Morcells™ Use in a Gunshot Wound
Author Name
Dr Christine Castater, MD, WellStar Kennestone Marietta, GA

Related Video

Patient Presentation

  • 36-Year-old male.
  • The patient received a gunshot injury to the face, resulting in a full thickness wound, where the bullet exited through his cheek resulting in parotid gland injury and fistula (Figure 1).
Figure 1
Figure 1

Procedure and Treatment

  • The patient was admitted to the operating room for embolization of the facial artery branches and to the parotid to stem leaking.
  • After receiving wound care for 7 days, Myriad Morcells (500 mg) was applied to the wound and into the areas of tunnelling (Figure 2).
  • The wound was dressed with Xeroform® and gauze.
Figure 2
Figure 2

Clinical Outcomes

  • Day 3. Newly forming granulation tissue could be observed as Myriad Morcells began to incorporate into the wound (Figure 3).
  • Day 7. Approximately 80% of the Myriad Morcells was incorporated into the wound. A significant amount of granulation tissue had formed and there were noticeable improvements in wound depth observed (Figure 4)
  • Day 10. Approximately 90% of Myriad Morcells had incorporated into the wound with granulation tissue filling the wound depth. The wound had also significantly reduced in size (Figure 5)
  • Week 4. The wound was 90% epithelialized with facial hair regrowth (Figure 6)
  • Week 6. The parotid fistula had completely resolved. Scarring was minimal and the patient was pleased with the cosmetic outcome (Figure 7)
Figure 3
Figure 3

 

Figure 4
Figure 4
Figure 5
Figure 5
Figure 6
Figure 6
Figure 7
Figure 7

Conclusions

  • Myriad Morcells can be used to assist in the rapid formation of well-vascularized and site-specific tissue formation. This is particularly useful areas of tunneling.
  • Myriad Morcells can help facilitate good cosmesis with minimal scarring.

Disclaimer

Myriad Morcells™ is a trademark of Aroa Biosurgery Limited.

Dr Castater has a consultancy agreement with Aroa Biosurgery.
September 2022 | MKT.1841.00

This presentation is only intended for viewing by healthcare practitioners, is of general nature and does not contain medical advice. Results may vary. Not all devices are registered and approved for sale in all countries or regions and indications for use may vary by country or region. Please contact your local representative for more information.

Advertisement

Advertisement

Advertisement